Journal of pharmacy and pharmaceutics Impact Factor 2023-2024 - ResearchHelpDesk

Journal of pharmacy and pharmaceutics Impact Factor 2023-2024 - ResearchHelpDesk - Journal of pharmacy and pharmaceutics - Pharmaceutical Sciences are one of the fastest growing fields of knowledge known for everlasting innovation. This field finds therapeutic solutions to innumerable healthcare challenges that the humanity encounters from time to time. Effective handling of public health issues largely depend on the way the pharmaceutical sciences reacts with fitting solutions, that include diagnosis, surgical, medicinal and rehabilitation practices. The Pharmaceutical Journals of Research and Review International deal with Hospital and Clinical Pharmacy, Pharma Research & Review, Pharmaceutical Quality Assurance, Pharmaceutics and Nanotechnology, Pharmacognosy and Phytochemistry and Toxicology.   Aim & Scope Journal of Pharmacy & Pharmaceutics is developed as an internationally peer reviewed journal to provide an unrestricted access in the fields of pharmacy and pharmaceutics. The title of the journal changed from Journal of Pharmaceutical Science and Drug Designing to Journal of Pharmacy & Pharmaceutics. Leading articles, meeting reports, critical commentaries, letters, and book reviews  dealing with pharmaceutical  sciences (Pharmacy, Pharmacognosy, Pharmaceutics, Pharmacokinetics, Pharmaceutical Analysis, Pharmacy Practice) etc are accepted. Journal of Pharmacy & Pharmaceutics follows the Creative Commons Attribution License and scholars open access publishing policies, readers can freely access the published articles through online with unique Digital Objective Identifier (DOI) provided by Cross Ref.

《药学与制药学杂志》2023-2024年影响因子 - 研究帮助台 - 《药学与制药学杂志》 - 药学科学是知识领域内增长速度最快的分支之一，以其永恒的创新而著称。该领域不断寻求治疗解决方案，以应对人类不时遭遇的众多医疗保健挑战。公共卫生问题的有效应对在很大程度上依赖于药学科学提供的适宜解决方案，这些解决方案包括诊断、外科、药物治疗和康复实践。国际研究评论型药学杂志涵盖医院与临床药学、药学研究与评论、药品质量保证、制药学与纳米技术、药理学与植物化学以及毒理学等领域。目标与范围：《药学与制药学杂志》系一国际同行评审期刊，旨在为药学与制药学领域提供无限制的访问。该刊原名《药物科学和药物设计杂志》，现更名为《药学与制药学杂志》。本刊接受关于药学科学（药学、药理学、制药学、药代动力学、药物分析、药学实践）等领域的领先文章、会议报告、批判性评论、信件和书评。本刊遵循创意共享署名许可和学者开放获取出版政策，读者可通过在线方式自由访问通过Cross Ref提供的具有独特数字对象标识符（DOI）的已发布文章。